FDA Approval for Resascope Soft: AMS obtained FDA approval for Resascope Soft
3 February 2021, by , in News, Comments off

We are proud to share with each and every one of you an incredible new milestone we have reached!! AMS GROUP is excited to inform you that we have obtained the FDA (Food & Drug Administration) approval for the Resascope Soft directable epidural catheter for the diagnosis and endoscopic treatment of the epidural space.

The tenacity that has always distinguished us, and which has led us to achieve this important result, will now guide us to face the new challenge that awaits us in the large US market!